Loading clinical trials...
Loading clinical trials...
An Open-Label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of a Single Dose of Oral Solithromycin Compared to Single-Dose Intramuscular Ceftriaxone Plus Single-Dose Oral Azithromycin in the Treatment of Male and Female Patients With Uncomplicated Urogenital Gonorrhea With or Without Concomitant Chlamydia
Conditions
Interventions
solithromycin
ceftriaxone
+1 more
Locations
5
United States
Baltimore, Maryland, United States
Cleveland, Ohio, United States
Toledo, Ohio, United States
Sydney, New South Wales, Australia
Melbourne, Victoria, Australia
Start Date
August 1, 2014
Primary Completion Date
February 22, 2017
Completion Date
February 22, 2017
Last Updated
September 11, 2017
Lead Sponsor
Melinta Therapeutics, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions